Nanopharm

Nanopharm is a contract research organisation specialising in the development of orally inhaled and nasal drug products, providing formulation development, materials characterisation, analytical testing, and in vitro and in silico modelling services to pharmaceutical and biotechnology clients.

The company supports development from preclinical through to cGMP clinical stages, including regulatory strategy.

Its proprietary platform enables bioequivalence demonstration for generic inhalation products without comparative clinical endpoint studies.